"Pediatric Sweet syndrome is rare, accounting for an estimated 5% to 8% of all Sweet syndrome cases. Pediatric HSS (histiocytoid Sweet's syndrome) is a histopathologic variant that is even more uncommon, with only 5 previous cases documented and all infantile cases having an identifiable underlying systemic association."
"Halpern et al reported that children with Sweet syndrome over 3 years of age were more likely to have an associated hematologic malignancy, whereas finding no predilection for either sex, whereas children under 3 with Sweet syndrome were predominantly male and had no associated malignancy. Preceding infection and underlying hematologic malignancy are the most common associated findings with Sweet syndrome in children."
"HSS has been associated with postinflammatory scarring, acquired cutis laxa, cardiovascular compromise, epiglottitis, gastrointestinal bleeding, and skin necrosis. Of these, cardiovascular sequelae, which include pericarditis, vessel dilation, valve disease, and myocardial infarction are the most severe and associated with the highest risk of mortality in the pediatric population."
- 11-month-old boy with a 3-month history of relapsing fevers ranging from 37.7 °C to 38.6 °C.
- Irritability and tender skin eruptions recurring every 5 to 6 days.
- Diagnosed with histiocytoid Sweet's syndrome. No underlying condition.
- Responded well to a 6-week course of oral prednisolone solution at a dose of 2.0 mg/kg/d.
ADDITIONAL NOTES:
HISTIOCYTOID SWEET'S SYNDROME.
In SS, mature white blood cells called neutrophils accumulate in the tissues. In HSS, immature myeloperoxidase-positive cells and not mature neutrophils can be seen. Myeloperoxidase is an enzyme that’s abundantly expressed in neutrophils.
The immature cells in HSS can be mistaken for histiocytes; immune cells that destroy foreign substances and help fight infection. Sometimes, real (authentic) histiocytes may also be present. ncbi.nlm.nih.gov/pmc/articl...